Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy.
about
Platelet-derived growth factor: a key factor in the pathogenesis of graves' ophthalmopathy and potential target for treatmentSafety Profile and Effects of Pulsed Methylprednisolone on Vital Signs in Thyroid Eye Disease.Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisited.Total thyroid ablation in Graves' orbitopathy.Graves' ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature.Chemodenervation of extraocular muscles with botulinum toxin in thyroid eye disease.Management of patients with thyroid eye disease.Radiotherapy for Graves' disease. The possible role of low-dose radiotherapyThyroid eye disease: a review.PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012.Volumetric Modulated Arc Therapy (VMAT) make a difference in retro-orbital irradiation treatment of patients with bilateral Graves' ophthalmopathy. Comparative analysis of dosimetric parameters from different radiation techniques.[Management of moderate and severe dysthyroid orbitopathy: about 22 cases].Natural history of graves' orbitopathy after treatment.A questionnaire survey on the management of Graves' orbitopathy in China: A comparison with Europe and Latin-America.Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future.Review of the treatment of Graves' ophthalmopathy: The role of the new radiation techniques.
P2860
Q27005680-00ABEA82-8F28-4F35-B746-272D23139636Q36349128-64C6DBD2-F5D5-44CF-9056-CFA83F83D17FQ37460205-8F9DAAD9-7F80-434B-8440-842C23C1F8A6Q38367695-519A47D3-52B2-4097-A473-C16E999C410EQ38607128-D8CF84C2-51ED-4657-A41C-A79228ABD2C0Q38727516-56BC50E4-52C2-41C7-AD80-E227FBFD679DQ38745704-86C8678B-7BE6-4AFF-80E8-E853725511F6Q38948145-0E8A4075-AD7E-4EE7-8E46-10C3D47FAE70Q38971992-A6E3D0C1-8CE3-409C-A10B-3D957BCDD244Q40962257-09D8A94F-D19C-44DF-880F-A273C2863CB5Q42022471-57F308C3-5DFD-4F49-9E06-C36D02D46337Q46190198-4780E782-B3B9-4089-8BCD-39DD4F94E4FDQ48318128-33064CD3-43F9-4EFC-A1BA-416F089B1199Q50957252-7E3C7A2B-EDE7-496F-98D8-FAC3FC9C2302Q55140443-2BFE0646-0BEE-43B1-A100-FEF5EC34753AQ55400137-6DD41F34-AAC5-4D9E-95BE-B7AD24A39453
P2860
Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy.
@en
type
label
Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy.
@en
prefLabel
Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy.
@en
P1476
Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy.
@en
P2093
Claudio Marcocci
Michele Marinò
P304
P356
10.1016/J.BEEM.2011.11.005
P577
2012-06-01T00:00:00Z